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ABSTRACT
Molecular beacons are dual-labelled probes that are
typically used in real-time PCR assays, but have
also been conjugated with solid matrices for use in
microarrays or biosensors. We have developed a
fluid array system using microsphere-conjugated
molecular beacons and the flow cytometer for the
specific, multiplexed detection of unlabelled nucleic
acids in solution. For this array system, molecular
beacons were conjugated with microspheres using
a biotin-streptavidin linkage. A bridged conjugation
method using streptavidin increased the signal-to-
noise ratio, allowing for further discrimination of
target quantitation. Using beads of different sizes
and molecular beacons in two fluorophore colours,
synthetic nucleic acid control sequences were spe-
cifically detected for three respiratory pathogens,
including the SARS coronavirus in proof-of-concept
experiments. Considering that routine flow cyto-
meters are able to detect up to four fluorescent
channels, this novel assay may allow for the specific
multiplex detection of a nucleic acid panel in a
single tube.
INTRODUCTION
With the continual emergence of new pathogens, the differ-
ential diagnosis or identiﬁcation of etiological agents is
the important ﬁrst step to control the spread of infection.
The SARS coronavirus (SARS-hCoV) tested the ability of
the scientiﬁc community to develop methods to isolate,
identify and characterize an emerging virus (1,2). The most
powerful etiological diagnostic was arguably the use of a
microarray ‘Viro-chip’, which was able to quickly reveal
that this pathogen was a coronavirus, even as it also found
that this particular coronavirus had never been described
previously (3). It appears that this type of solid-phase array
technology will become more routine as the costs decrease, the
procedures become streamlined for practical use and the
technology becomes better disseminated. Current tests for
nucleic acid detection are based upon real-time PCR assays
(4). In these assays, non-speciﬁc (SYBR) or probe-speciﬁc
ﬂuorescence is measured throughout the PCR reaction
[reviewed in (5)].
Tyagi and Kramer (6) published work describing
single-stranded ‘loop-and-stem’ molecules carrying both a
ﬂuorochrome and a quencher in close proximity. In this
conﬁguration, energy emitted by the excited ﬂuorochrome
is absorbed by the quencher and dissipated as heat in a process
called ﬂuorescence resonance energy transfer (FRET). When
the loop binds to a complementary nucleic acid strand, the
molecule changes its conformation to distance the ﬂuo-
rochrome from the quencher, allowing unquenched ﬂuores-
cence. These molecules were called ‘molecular beacons’
because they emit a ﬂuorescent signal only when the probes
are hybridized to their targets (6). Itwas later shownthat it was
possible to build multiplexed assays with this method; differ-
ently labelled molecular beacons could recognize different
targets in the same reaction tube (7). It was also shown that
the speciﬁcity of the assay was very high, so that probes
differing in only 1 nt could be resolved (8). Various assays
were then published using the molecular beacons technology,
ranging from mRNA in situ visualization (9,10) to nucleic acid
sequence-based ampliﬁcation detection (11), and multiplex
detection of four pathogenic retroviruses (12). In other appli-
cations, molecular beacon probes were designed for use as
DNA biosensors by binding molecular beacons to glass
beads or cover slips (13), ultra small optical ﬁbre probes
(14) and gold surfaces (15), allowing the speciﬁc detection
of complementary sequences.
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doi:10.1093/nar/gni015Flow cytometers are common diagnostic tools used in the
immunophenotyping of immune system cells or in the
characterization of blood malignancies. With a routine
conﬁguration, they allow for the contemporary measurement
of four different ﬂuorescent wavelengths, in addition to two
signals related to cell size and internal complexity. As such,
their application is possible only when the ﬂuorescent signal is
associated with discrete particles, such as cells in suspension
or microparticles. The ﬂow cytometer has recently been used
todetectnucleic acidsinamultiplexedformat using secondary
reagents for signal detection (16).
In this report, we describe the construction of molecular
beacon-conjugated beads that we have called ‘BeadCons’,
whose speciﬁc hybridization with complementary target
sequences can be resolved by ﬂow cytometry (see Figure 1).
Assay sensitivity is achieved through the concentration
of ﬂuorescence signal on discrete particles. We ﬁrst
obtained evidence that the method could work in principle,
with the ability to detect single, synthetic target sequences.
Then, we set up the system in a multiplex format (array),
and applied the method to nucleic acid oligonucleotides
mimicking respiratory diagnostic sequences. The results
indicated that this method could allow the detection of the
corresponding oligonucleotide, even when diluted in a
complex mixture of nucleic acids. In fact, the versatility of
ﬂow cytometers allows the resolution of very complex
analytical mixtures, in which the hybridized beads of a
speciﬁc size and/or colour can be readily distinguished from
the others that are unbound. The short assay time and ease-of-
use makes this method a good candidate for a further devel-
opment of its diagnostic capabilities and use in the routine
laboratory.
Figure 1. Schematic representation of the interaction of the bead-bound molecular beacon with a complementary nucleic acid. The molecular beacon contains a
probing loop sequence embedded withincomplementary arm sequences. These arms form a hairpin stem that keeps a terminal fluorophore and a terminalquencher
moleculeincloseproximityintheabsenceofnucleicacidthatiscomplementarytotheloop.ThisstateallowsforFRET,oratransferofenergyfromthefluorophoreto
thequencherratherthanexcitationuponabsorbance.Aftertargetaddition,thecomplementarytargetformsaduplexwiththeloopportionofthebeaconthatpullsthe
fluorophore and quencher from close proximity, allowing fluorescence. The molecular beacon sequences are linked to the microspheres using a biotinylated
thymidine in the stem sequence proximal to the quencher.
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Nucleic acids
Previously published molecular beacon and ssDNA comple-
mentary control sequences were synthesized for hepatitis C
virus (HCV) (17).Molecular beacons and ssDNA complemen-
tary controls were designed for parainﬂuenza virus type 3
(PIV-3), respiratory syncytial virus (RSV), SARS-hCoV-M
and SARS-hCoV-N using Beacon Designer 2.1 software
(Premier Biosoft International, Palo Alto, CA). All beacons
were designed with a thymidine on the 30 stem proximal to the
quencher molecule, allowing for the addition of biotinylated
thymidine in the synthesis process (see Table 1 for beacon
sequences). The molecular beacons were ordered with 6-FAM
as the reporter dye, BHQ-1 as the dark quencher and the
biotinylated thymidine on the 30 stem (Biolegio, The
Netherlands). The molecular beacons for the SARS-hCoV
were also ordered with the Cy5/BHQ-2 ﬂuorescence/quencher
pair. All molecular beacon and positive control sequences are
listed in Table 1.
Bead preparation
Aliquots containing 3.3 mm streptavidin-coated microspheres
(G. Kisker GbR, Steinfurt, Germany) were used in a direct
conjugation with the biotinylated molecular beacons.
Aliquots containing 3.3 and 6.7 mm biotinylated microspheres
(G. Kisker GbR) were used in a streptavidin-bridged bead
design. Streptavidin (10 ml of 5 mg/ml; Roche) was diluted
to a volume of 110 ml in FACSFlow solution (10 mM
phosphate-buffered saline, 150 mM NaCl, pH 7.4;
Becton-Dickinson), the biotinylated beads (10 mlo f
0.5% w/v) were added to the buffer and this mixture was
incubated for 5 min at room temperature. The beads were
then washed twice with FACSFlow to eliminate unbound
streptavidin. The biotinylated molecular beacon (5 mlo f
100 mM) was added to the streptavidin-bridged or
streptavidin-coated beads (10 ml of 0.5% w/v), diluted to a
total of 100 ml in FACSFlow and incubated for 5 min at room
temperature. These BeadCons were washed twice in FACS-
Flow and stored at room temperature until use.
Sample preparation and hybridization
Control samples were analyzed using oligonucleotides
complementary to the hybridizing loop sequence (Table 1).
The beads were washed with FACSFlow and aliquoted to
 5 · 10
4 beads/test in 100 ml. The complementary nucleic
acid (10 mlo fa1 0mM stock) was then added to the test beads.
In the multiplex detection experiment, the test sample con-
tained 0.5 ml of the positive oligo DNA (100 mM stock) diluted
in 9.5 ml of a complex mixture of oligonucleotides (equimolar
levels of 10 mM each, equalling a 100 mM total concentration;
sequences listed in Supplementary Table 1). For the mismatch
analysis, 10 ml of a 100 nM stock for each oligonucleotide was
used (sequences listed in Supplementary Table 2). The sam-
ples were hybridized with gentle agitation for 5 min at room
temperature before reading. An aliquot of 200 ml of FACS-
Flow was added to each tube to run the sample on the ﬂow
cytometer.
Flow cytometry and analysis
A minimum of 1 · 10
4 events were collected for each sample
(ﬂow cytometry conditions for the FACSCalibur machine are
listed in Supplemental Table 3). The data were analyzed using
CellQuest 3.3 (BD Biosciences, San Jose, CA). A positive
threshold was set for each BeadCon, based upon the highest
ﬂuorescent point seen in the negative control sequence
(for all BeadCons, an HIV complementary sequence was
used; the sequence is listed in Supplementary Table 2). Mean
ﬂuorescence intensities (MFIs) were recorded for the FL1
(6-FAM) and FL3 (Cy5) channels on gated BeadCons
populations.
RESULTS
A marked shift in fluorescence intensity is seen
using flow cytometry after the addition of
loop-specific sequence
BeadConswerepreparedasdescribedinMaterialsandMethods
to test whether the system is functional. A molar excess of
biotinylated molecular beacon speciﬁc for HCV was added
to 6.7 mm streptavidin-bound microspheres. It is important to
note that the biotinylated thymidine in the molecular beacon
is on the stem proximal to the quencher molecule as described
previously (13). Target DNA was then added to the washed
beads to determine whether there was a shift in the mean ﬂuo-
rescence of the beads. An HCV-speciﬁc positive control
DNA yielded an MFI of 27.0 – 1.5 compared with an MFI
of2.06–0.11foranHIVtargetsequence(seeFigure2).There-
fore,thesignal-to-noiseratio(STNR)forthemolecularbeacons
with a direct conjugation to the beads was 13.1, higher than the
2–5 STNR of other molecular beacon systems that use a solid
or immobilized phase (18,19), but lower than the standard 25
STNR that is typically seen in solution (6,20,21).
Table 1. Molecular beacon sequences for BeadCons analysis
Target Sequence
a
HCV
MB 50-6-FAM-GCGAGCCACCGGAATTGCCAGG-
ACGACCGCTCGC-BHQ-1-30
K+ 50-GGTCGTCCTGGCAATTCCGGTG-30
PIV-3
MB 50-6-FAM-ACCATGCGCACCCAGTTG-
TGTTGCAGATTCGCATGGT-BHQ-1-30
K+ 50-AATCTGCAACACAACTGGGTG-30
RSV
MB 50-6-FAM-CGCGATCTTCTCCAGTGTAG-
TATTAGGCAATGCGATCGCG-BHQ-1-30
K+ 50-GCATTGCCTAATACTACACTGGAGAA-30
SARS-M*
MB 50-Cy5-CGCGATAACAGCCTGAAGGAAGCAA-
CGAAATCGCG-BHQ-2-30 (also 6-FAM/BHQ-1)
K+ 50-TTCGTTGCTTCCTTCAGGCTGTT-30
SARS-N*
MB 50-Cy5-CGCGATCCCAAAAGGCTTCTACGCAG-
AGGGAAGATCGCG-BHQ-2-3 (also
6-FAM/BHQ-1)
K+ 50-CTTCCCTCTGCGTAGAAGCCTTTTGGG-30
thymidine in each MB 30stem sequence is listed in bold.
aTheloopportionofeachmolecularbeacon(MB)isunderlinedandthepositive
controls (K+) used in these studies are listed below each MB. The biotinylated
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increases the STNR
The commercial availability of biotinylated beads led us totest
the possibility of using streptavidin to bridge the beacon and
bead. Such an approach has previously been used to increase
the signal of molecular beacons as functional biosensors (13).
Streptavidin was added to 6.7 mm biotinylated beads in
excess to limit the possibility of bead cross-linking, with a
high enough level of streptavidin so that no two beads would
share a single streptavidin molecule. Initial experiments with
lower streptavidin levels revealed the production of a doublet
population, formed as a streptavidin molecule-bridged two
biotinylated beads. When prepared and thoroughly washed
beads were hybridized with the HCV-speciﬁc positive control
DNA, an MFI of 49.8 – 3.6 was seen compared with an MFI of
2.06 – 0.15 for the unrelated HIV control. Therefore, an STNR
of 24.1 was achieved through the use of a streptavidin bridge,
comparable with the typical, optimized results in solution for
this ﬂuorophore/quencher set. An asymmetrical PCR product
derived from an HCV-infected serum sample yielded an MFI
of 14.1 – 0.9, for an STNR of 6.8 (Supplementary Figure 1).
ThereductioninSTNR isprobably due toself-annealing ofthe
ampliﬁed asymmetric PCR strand; however, qualitative gating
showed that the binding of the single-stranded product was
much more effective than that of the symmetric PCR product
(negative using the current hybridization conditions).
The assay is sensitive across a four orders of
magnitude range
AllthetestBeadConswereassayedfortheirdynamicdetection
range.Afteraninitial100-folddilutionofa10mMstock,5-fold
dilutions of positive oligonucleotide controls were made
in FACSFlow buffer and 10 ml were added to the BeadCons
that were built using the streptavidin bridging. It must be
noted that the PMT voltage setting was slightly increased for
theFL1channel(from400to420)toincreasetheMFIand,thus,
differences between the beads with little or no positivity.
A representative detection curve is shown in Figure 3. For
this example, the limit of detection (10 SDs above the back-
groundMFIof3.70)forthisBeadConspeciﬁcforSARS-Nwas
found to be26 fmol atan MFIof 5.7. The dynamic detectionof
this assay extended to 100 pmol, revealing a working range of
nearly four orders of magnitude. The other BeadCons tested
using this method (including those for HCV, PIV-3, RSV and
SARS-M) showed an average limit of detection at 37 fmol
(range: 26–56 fmol).
Specificity of the BeadCons with mismatched
nucleotides
Previous work with molecular beacons demonstrates that sin-
gle nucleotide polymorphisms can be detected in PCR assays
(22). Using a previously published HCV sequence as the
Figure 2. Bridged conjugation of the molecular beacon to the microsphere expands the STNR of the system. Biotinylated molecular beacons were directly
conjugatedtostreptavidin-labelledbeadsintheoriginalassessmentoftheassay.AnSTNRof13.1wasseenfora6-FAM/BHQ-1BeadConforSARS-hCoV-Ngene.
Thesamebeaconwasconjugatedtobiotinylatedbeadsthroughastreptavidinbridgethatallowedforanamplificationofthefluorescence.TheSTNRforthebridged
beacon,24.1,isnearlydoublethatofthedirectlyconjugatedBeadCon.Thisresultwasfoundinanexperimentaltriplicate,andSDsoftheMFIdataarelistedinthetext.
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were studied for their binding characteristics (sequences listed
in Supplementary Table 2; for results, see Figure 4). Using this
assay under initial conditions, a single nucleotide difference
could not be statistically distinguished from the positive
control sequence. The same experiment was repeated using
a 5 min incubation at 80 C for hybridization, with or without
the addition of 25 mM MgCl2. These hybridization conditions
allowed a better resolutionof nucleotide mismatches, although
there was a small loss in the overall STNR in the assay (see
Figure 4A). Finally, the analysis was repeated using the
SARS-N BeadCon. Using the new hybridization conditions
(80 C with 25 mM MgCl2), the single nucleotide mismatch
for SARS-N generated a ﬂuorescence that was 24% lower than
the complementary positive control. A 3 nt mismatch showed
a 91% loss of ﬂuorescence compared with the positive control,
at a level very similar to that of the complete mismatch oligo
from HIV (see Figure 4B).
A multiplex array of respiratory pathogen BeadCons
showed specific identification of the corresponding
oligonucleotide
To test whether both multiple bead sizes and ﬂuorochromes
could be used simultaneously, molecular beacons that
incorporated the Cy5/BHQ-2 ﬂuorochrome/quencher set were
synthesized for the SARS-hCoV-M and -N open reading
frames. The BeadCons for these targets were constructed
using the same conditions as for the other probes, with
conjugation to streptavidin-bridged 3.3 and 6.7 mm beads.
BeadCons against RSV (3.3 mm) and PIV-3 (6.7 mm) were
also constructed using the 6-FAM/BHQ-1 ﬂuorochrome/
quencher set. An aliquot of 50 pmol of each pathogen oligo
sequence was diluted in 950 pmol of a mixture of oligonu-
cleotides with no speciﬁcity for the beacon sequence (oligonu-
cleotide sequences are listed inSupplementary Table 2).When
these DNAs were added to the BeadCons mixture of four
targets, the corresponding BeadCon showed a ﬂuorescent
shift above background, conﬁrming presence of that target
in the tube (see Figure 5). It should be noted that the
‘SARS’ tube contained 50 pmol of both SARS-M and
SARS-N oligonucleotides, and both BeadCons showed a posi-
tive shift in ﬂuorescence. Without speciﬁc target addition, the
BeadCons failed to ﬂuoresce above background. The MFI,
STNR and corresponding SDs are listed for three experimental
replicates of the shown, representative dot plots. All ﬂuores-
cence shifts were signiﬁcant to the levels shown in the ﬁgure
by utilizing the unpaired t-test using Welch’s correction.
DISCUSSION
The development of a highly accessible and easily adaptable
multiplex system for the detection of pathogens remains the
ultimate goal for the molecular diagnostic laboratory. Real-
time PCR has been a very useful tool in the research ﬁeld as
it allows for the rapid, simultaneous detection of pathogens in
multiplex. Unfortunately, the multiplex PCR system is com-
plex for assay development, as primer/probe sets must be
matched for primer melting temperature (Tm), probe Tm,
amplicon length and amplicon Tm. Obviously, each additional
target also adds another level of complexity to the assay
Figure 3. The detection limit of this assay is within the fmol concentration of
targetnucleicacid.ThisBeadConforSARS-CoV-Nwassensitiveto26fmolof
complementary DNA using 10
4 beads and the described conditions (triplicate
results averaged). Other tested BeadCons had similar limits of detection,
ranging from 26 to 56 fmol with an average of 37 fmol.
Figure4.MismatchednucleotideanalysistotestthespecificityoftheBeadCons.(A)Ameasureoffluorescencerelativetothatofthepositivecontrolformismatched
targetsusingtheindicatedconditions.ForthepreviouslydescribedHCVmolecularbeacon,hybridizationat80 Cwith25mMMgCl2increasedthespecificity,witha
small loss in assay sensitivity. The SARS-N BeadCon showed a higher level of discrimination for multiple mismatches under the same conditions, maintaining
an STNR of over 20. (B) The histograms of SARS-N BeadCon fluorescence present an illustrative example of the analysis.
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Microarrays will probably allow for the rapid screening of
thousands of possible pathogens, but the cost, equipment
and expertise make current routine use impossible, and
this type of solid-phase array technology will not be practical
as a clinical diagnostic for some years. There remains a
need for the continual development and reﬁnement of assays
that can be used to detect nucleic acids in a multiplexed
format.
We have developed molecular beacon-labelled micro-
spheres with a read-out on the ﬂow cytometer for the multi-
plexed detection of nucleic acids in solution. A bridging
approach allowed the speciﬁc binding of the BeadCon by
the proper complementary DNA sequence. The bridging of
the BeadCon using a streptavidin molecule increased the
STNR 2-fold to levels that are similar to those seen for
molecular beacons in solution. The commercial source of
the beads that were used in these studies conﬁrmed that the
streptavidin beads carriedthreetimes asmany bindingsites for
biotin as the biotinylated beads did for streptavidin. Therefore,
if each streptavidin of the bridged molecule allows complete
accessibility of all three available sites for biotin, the STNR
should be roughly about the same. As the STNR was twice
as high for the bridged molecule, it is likely that the bridging
helps to overcome the surface effects that are often seen using
solid state nucleic acid detection systems (19). As the molecu-
lar beacons are more accessible for the target, there is a more
effective loss of FRET and, thus, an increase in maximal
ﬂuorescence.
The individual speciﬁcity and sensitivity of each molecular
beacon must be developed speciﬁcally for this assay. It
appears that currently designed methods for use in PCR
must be modiﬁed if increased speciﬁcity is required. For
the HCV BeadCon used in our studies at room temperature,
a 3 nt mismatch was readily detectable at a level that was
virtually indistinguishable from the matched positive control.
As this reaction was hybridized and measured at room tem-
perature, mismatched hybridization is expected as it is difﬁcult
to distinguish mismatches at temperatures below the ’window
of discrimination’ for each beacon (20,22,23). In this tempera-
ture range, it is possible to discriminate a single nucleotide
polymorphism; however, as the temperature decreases to
25 C, the difference in ﬂuorescence between mismatched tar-
gets is negligible. The currently designed beacons are used to
measure ﬂuorescence at an elevated annealing temperature,
which fails to allow mismatched target duplexes and, thus,
ﬂuorescence (20). An assay that allows mismatching can be
useful in detecting nucleic acids that have point mutations
from their homologous sequence. Alternatively, the dynamics
ofthe binding reaction couldbealteredbychangingthe Gibb’s
free energy assignments of the stem and loop regions of the
molecular beacon. The SARS-N molecular beacon that we
designed showed a better discrimination of mismatched
targets, although it appears that the spacing of the mismatches
may play a role. The binding properties can be modiﬁed
by altering the backbone of the beacon (such as for a peptide
nucleic acid), substituting high afﬁnity nucleotides for normal
ones (such as in a locked nucleic acid), or by changing the
Figure5.Qualitativedetectionofthreerespiratoryvirussequencesinmultiplex.ABeadConsarraywasgeneratedusingtwobeadsizesandtwofluorescencemarkers
asdescribedinthetext.TheadditionofPIV-3,RSVorSARS-h-CoV(genesMandN)DNAcontrolsequencesthatweredilutedinacomplexDNAmixtureallowed
the specific identification of the target compared with negative controls. In effect, each panel shows an internal negative control, as each test was carried out using
a complex DNA mixture. The black arrows note the positive shift in fluorescence.
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types of molecular beacons will probably be used more in
the future, as these complex synthesis technologies are
improved and better diffused.
In assay development for each group of targets, it
will be necessary to consider whether single nucleotide
polymorphism detection will be developed through these
means, or if it is better for the system to be tolerant for
small nucleotide changes that would allow detection even
as the target sequence contains mutations. Unique sequences
can be selected for each target, allowing speciﬁc detection.
In addition, redundancy can be included within the assay by
conjugating molecular beacons for multiple sequences of the
same pathogen or gene onto a single type of bead. The further
development of this assay to detect a single target from a
complex mixture may be important in several ﬁelds of use.
We hope to facilitate differential diagnosis, genetic testing,
genotyping and gene expression studies through the use of
this technology.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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